CN Patent

CN105142641A — 用于治疗癌症的化合物

Assigned to Curegenix Inc · Expires 2015-12-09 · 10y expired

What this patent protects

本发明涉及作为WNT信号传导通路的抑制剂的化合物以及包含该化合物的组合物。进一步而言，本发明涉及所述化合物在治疗癌症中的应用。

USPTO Abstract

本发明涉及作为WNT信号传导通路的抑制剂的化合物以及包含该化合物的组合物。进一步而言，本发明涉及所述化合物在治疗癌症中的应用。

Drugs covered by this patent

Patent Metadata

Patent number: CN105142641A
Jurisdiction: CN
Classification: —
Expires: 2015-12-09
Drug substance claim: No
Drug product claim: No
Assignee: Curegenix Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.